Although exposure of diabetogenic CD4+ T-cells derived from BDC2.5 transgenic mice to TNF-α resulted in the suppression of T cell responses in vitro and altered expression of several genes involved in signaling pathways coupled to the T cell receptor, it is not known whether these alterations can impact the manifestation of diabetes [37]. This evidence concerns the gene CD4 and diabetes mellitus.